Detalles de la búsqueda
1.
Identification of Very Low-Risk Subgroups of Patients with Primary Mediastinal Large B-Cell Lymphoma Treated with R-CHOP.
Oncologist
; 26(7): 597-609, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33870594
2.
Real-life experience with the combination of polatuzumab vedotin, rituximab, and bendamustine in aggressive B-cell lymphomas.
Hematol Oncol
; 39(3): 336-348, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-33583077
3.
Positron emission tomography after response to rituximab-CHOP in primary mediastinal large B-cell lymphoma: impact on outcomes and radiotherapy strategies.
Ann Hematol
; 100(9): 2279-2292, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-33523289
4.
Real-world data on incidence, clinical characteristics and outcome of patients with macrofocal multiple myeloma (MFMM) in the era of novel therapies: A study of the Greco-Israeli collaborative myeloma working group.
Am J Hematol
; 95(5): 465-471, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32048329
5.
Effect of induction therapy with lenalidomide, doxorubicin and dexamethasone on bone remodeling and angiogenesis in newly diagnosed multiple myeloma.
Int J Cancer
; 145(2): 559-568, 2019 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30650184
6.
Evaluation of regulatory T cells (Tregs) alterations in patients with multiple myeloma treated with bortezomib or lenalidomide plus dexamethasone: correlations with treatment outcome.
Ann Hematol
; 98(6): 1457-1466, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-30895351
7.
Is it possible to cure myeloma without allogeneic transplantation?
Transfus Apher Sci
; 54(1): 63-70, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26850930
8.
Lack of survival improvement with novel anti-myeloma agents for patients with multiple myeloma and central nervous system involvement: the Greek Myeloma Study Group experience.
Ann Hematol
; 94(12): 2033-42, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26420061
9.
Treatment with bortezomib-based regimens improves overall response and predicts for survival in patients with primary or secondary plasma cell leukemia: Analysis of the Greek myeloma study group.
Am J Hematol
; 89(2): 145-50, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24123068
10.
Clinical features, outcome, and prognostic factors for survival and evolution to multiple myeloma of solitary plasmacytomas: a report of the Greek myeloma study group in 97 patients.
Am J Hematol
; 89(8): 803-8, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24757085
11.
Chronic myelogenous leukemia occurring in two brothers: The opposite sides of the same coin?
Leuk Res Rep
; 16: 100261, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34401318
12.
Real-world data on prognosis and outcome of primary plasma cell leukemia in the era of novel agents: a multicenter national study by the Greek Myeloma Study Group.
Blood Cancer J
; 8(3): 31, 2018 03 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29523783
13.
A rare case of autoimmune hemolytic anemia during venetoclax therapy for relapsed chronic lymphocytic leukemia.
Leuk Lymphoma
; 62(12): 3054-3056, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34151719
14.
Visceral Leishmaniasis in 2 Patients Treated With Lenalidomide and Dexamethasone: A Possible Correlation With Blunted Immune Response.
Hemasphere
; 5(1): e506, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-33324952
Resultados
1 -
14
de 14
1
Próxima >
>>